Fecal Transplants Show Mixed Results for Boosting Cancer Immunotherapy
New review reveals why fecal microbiota transplants sometimes helpβand sometimes hurtβimmune checkpoint inhibitor cancer treatments.
249 articles in this topic
New review reveals why fecal microbiota transplants sometimes helpβand sometimes hurtβimmune checkpoint inhibitor cancer treatments.
Scientists develop bacteria that colonize tumors and secrete proteins to highlight cancer tissue with 15x better contrast than current methods.
New study shows combining PET scans with blood DNA tests can identify follicular lymphoma patients at high risk of early relapse.
Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.
Real-world study of 664 patients reveals effective treatment options after T-DXd discontinuation, with low lung disease recurrence rates.
Large study reveals cancer survivors have higher biological age than cancer-free individuals, with strongest mortality predictions from epigenetic clocks.
Scientists discover how breast cancer builds deadly metastases using a 3D branching pattern, revealing new treatment targets.
Rare genetic syndrome caused by TP53 mutations leads to extraordinarily high lifetime cancer risk, with new prevention strategies emerging.
Revolutionary blood tests can detect cancer DNA fragments, enabling earlier diagnosis and better treatment monitoring.
New immunotherapies and targeted drugs show promise for treating aggressive hepatobiliary cancers through innovative approaches.
New research shows brief fasting periods can boost the effectiveness of cancer immunotherapy by reshaping tumor-fighting immune cells.
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.